CN Patent

CN111004257B — 制备RET抑制剂Selpercatinib的方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2021-06-29 · 5y expired

What this patent protects

本发明涉及一种制备RET抑制剂Selpercatinib的方法。本发明所述的制备方法，其卤化反应条件更温和，反应操作步骤及后处理更简便，反应步骤少，大幅度提高了反应的总产率，产物纯度达到99.0％以上。

USPTO Abstract

本发明涉及一种制备RET抑制剂Selpercatinib的方法。本发明所述的制备方法，其卤化反应条件更温和，反应操作步骤及后处理更简便，反应步骤少，大幅度提高了反应的总产率，产物纯度达到99.0％以上。

Drugs covered by this patent

Patent Metadata

Patent number
CN111004257B
Jurisdiction
CN
Classification
—
Expires
2021-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.